Alligator Bioscience cancer therapy
Alligator's CEO comments on the restructuring plan
Alligator Bioscience started the year strong by achieving the primary endpoint of the Phase II OPTIMIZE-1 study with its lead candidate...
Intervju
Video
Alligator Biosciences CEO about the issue
Alligator Bioscience develops tumor-targeted antibody-based treatments for cancer....
Intervju
Video
Alligator prepares for new milestones with mitazalimab
The objective response rate of 52 percent measured with...